- Investing Ideas
- /
- German Undervalued Stocks Based On Cash Flows
German Undervalued Stocks Based On Cash Flows
Results
26
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
26 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
HNL | €17.50 | 6.1% | -22.2% | €106.1m | €25.20 | PS1.1x | E121.4% | n/a | Capital Goods | ||
SBS | €42.00 | -5.6% | -17.2% | €510.5m | €42.33 | PE42x | E21.9% | 1.3% | Healthcare | ||
RTV | €2.48 | -3.1% | -1.6% | €38.6m | €2.80 | PS13.5x | E116.8% | n/a | Media | ||
STM | €43.70 | -2.6% | -17.8% | €1.1b | €63.44 | PE14.7x | E20.5% | 4.0% | Capital Goods | ||
CHG | €24.20 | -1.6% | 66.9% | €473.1m | €27.00 | PS6.7x | E73.4% | n/a | Healthcare | ||
TTR1 | €17.00 | -4.8% | -35.6% | €117.4m | €21.50 | PE18.4x | E29.4% | 3.6% | Capital Goods | ||
MTX | €247.70 | -1.0% | 8.1% | €13.3b | €248.90 | PS2.4x | E34.9% | 0.8% | Capital Goods | ||
RSL2 | €18.40 | -0.5% | -17.1% | €118.5m | €30.00 | PB1.7x | E58.9% | 0% | Capital Goods | ||
E4C | €12.65 | -3.1% | -32.9% | €44.4m | €40.50 | PE29.3x | E46.7% | 3.7% | Telecom | ||
AEIN | €17.05 | -0.6% | -27.9% | €195.1m | €32.63 | PE14.6x | E25.2% | 2.9% | Software | ||
ADS | €228.70 | -1.2% | 30.8% | €40.8b | €233.18 | PE480.4x | E41.0% | 0.3% | Consumer Durables | ||
SANT | €20.14 | 0.4% | 4.9% | €1.2b | €30.42 | PE16.6x | E21.1% | 2.5% | Software | ||
SAP | €183.62 | -2.2% | 53.3% | €212.8b | €199.16 | PE82.6x | E34.0% | 1.2% | Software | ||
ST5 | €32.40 | 5.2% | -3.3% | €456.3m | €39.50 | PE27x | E20.6% | 0% | Capital Goods | ||
V3S | €10.60 | -2.3% | 90.0% | €85.4m | €10.25 | PS2.3x | E118.7% | 0% | Tech | ||
R3NK | €24.92 | -4.2% | n/a | €2.5b | €31.88 | PE79.1x | E32.8% | 1.2% | Capital Goods | ||
ISHA | €2.04 | 1.0% | 7.4% | €29.7m | €2.60 | PB2.7x | E80.5% | n/a | Software | ||
GXI | €96.45 | -4.2% | -9.5% | €3.3b | €134.06 | PE28.9x | E22.3% | 1.3% | Pharmaceuticals & Biotech | ||
M12 | €15.75 | -8.4% | 95.4% | €288.5m | €27.50 | PE28.1x | E24.4% | 3.2% | Healthcare | ||
BSL | €10.92 | -0.7% | -31.8% | €335.6m | €15.70 | PS1.8x | E84.0% | 0% | Tech | ||
LPK | €7.99 | -5.3% | -2.6% | €195.6m | €12.05 | PE59x | E51.7% | n/a | Tech | ||
EQS | €39.40 | 0% | 90.3% | €394.9m | €37.50 | PS5.5x | E115.5% | 0% | Software | ||
SJJ | €11.80 | 8.3% | 38.5% | €123.9m | €19.75 | PS1.3x | E111.5% | 0% | Software | ||
MBB | €107.00 | 0% | 34.8% | €611.7m | €123.00 | PE33x | E33.5% | 0.9% | Capital Goods |